313 related articles for article (PubMed ID: 3277717)
1. A non-AUG translational initiation in c-myc exon 1 generates an N-terminally distinct protein whose synthesis is disrupted in Burkitt's lymphomas.
Hann SR; King MW; Bentley DL; Anderson CW; Eisenman RN
Cell; 1988 Jan; 52(2):185-95. PubMed ID: 3277717
[TBL] [Abstract][Full Text] [Related]
2. Functional analysis of the AUG- and CUG-initiated forms of the c-Myc protein.
Blackwood EM; Lugo TG; Kretzner L; King MW; Street AJ; Witte ON; Eisenman RN
Mol Biol Cell; 1994 May; 5(5):597-609. PubMed ID: 7919540
[TBL] [Abstract][Full Text] [Related]
3. Altered c-myc RNA metabolism in Burkitt's lymphomas and mouse plasmacytomas.
Piechaczyk M; Bonnieu A; Eick D; Remmers E; Yang JQ; Marcu K; Jeanteur P; Blanchard JM
Curr Top Microbiol Immunol; 1986; 132():331-8. PubMed ID: 3024921
[No Abstract] [Full Text] [Related]
4. Two N-myc polypeptides with distinct amino termini encoded by the second and third exons of the gene.
Mäkelä TP; Saksela K; Alitalo K
Mol Cell Biol; 1989 Apr; 9(4):1545-52. PubMed ID: 2657399
[TBL] [Abstract][Full Text] [Related]
5. The block of elongation in c-myc exon 1 is abolished in Burkitt's lymphoma cell lines with variant translocation.
Eick D; Polack A; Kofler E; Bornkamm GW
Oncogene; 1988 Oct; 3(4):397-403. PubMed ID: 3078949
[TBL] [Abstract][Full Text] [Related]
6. The block to transcription elongation is promoter dependent in normal and Burkitt's lymphoma c-myc alleles.
Spencer CA; LeStrange RC; Novak U; Hayward WS; Groudine M
Genes Dev; 1990 Jan; 4(1):75-88. PubMed ID: 2307371
[TBL] [Abstract][Full Text] [Related]
7. Antiimmunoglobulin inhibition of Burkitt's lymphoma cell proliferation and concurrent reduction of c-myc and mu heavy chain gene expression.
Arasi VE; Lieberman R; Sandlund J; Kiwanuka J; Novikovs L; Kirsch I; Hollis G; Magrath IT
Cancer Res; 1989 Jun; 49(12):3235-41. PubMed ID: 2497974
[TBL] [Abstract][Full Text] [Related]
8. Suppression of the malignant phenotype in somatic cell hybrids between Burkitt's lymphoma cells and Epstein-Barr virus-immortalized lymphoblastoid cells despite deregulated c-myc expression.
Wolf J; Pawlita M; Bullerdiek J; zur Hausen H
Cancer Res; 1990 May; 50(10):3095-100. PubMed ID: 2159373
[TBL] [Abstract][Full Text] [Related]
9. Effect of somatic mutation within translocated c-myc genes in Burkitt's lymphoma.
Rabbitts TH; Forster A; Hamlyn P; Baer R
Nature; 1984 Jun 14-20; 309(5969):592-7. PubMed ID: 6547209
[TBL] [Abstract][Full Text] [Related]
10. Expression and characterization of a protein encoded by the human c-myc exon 1 in Escherichia coli.
Psallidopoulos MC; Seth A; Dubois GC; Fisher RJ; Papas TS
Gene Anal Tech; 1989; 6(3):47-56. PubMed ID: 2524439
[TBL] [Abstract][Full Text] [Related]
11. Novel promoter upstream of the human c-myc gene and regulation of c-myc expression in B-cell lymphomas.
Bentley DL; Groudine M
Mol Cell Biol; 1986 Oct; 6(10):3481-9. PubMed ID: 3540591
[TBL] [Abstract][Full Text] [Related]
12. The c-MYC allele that is translocated into the IgH locus undergoes constitutive hypermutation in a Burkitt's lymphoma line.
Bemark M; Neuberger MS
Oncogene; 2000 Jul; 19(30):3404-10. PubMed ID: 10918597
[TBL] [Abstract][Full Text] [Related]
13. Clustered mutations in the second exon of the MYC gene in sporadic Burkitt's lymphoma.
Yano T; Sander CA; Clark HM; Dolezal MV; Jaffe ES; Raffeld M
Oncogene; 1993 Oct; 8(10):2741-8. PubMed ID: 8397370
[TBL] [Abstract][Full Text] [Related]
14. Lymphomagenesis in Emu-myc transgenic mice does not require transgene rearrangement or mutation of myc exon 1.
Webb E; Barri G; Cory S; Adams JM
Mol Biol Med; 1989 Dec; 6(6):475-80. PubMed ID: 2699507
[TBL] [Abstract][Full Text] [Related]
15. Mutations in the first exon are associated with altered transcription of c-myc in Burkitt lymphoma.
Cesarman E; Dalla-Favera R; Bentley D; Groudine M
Science; 1987 Nov; 238(4831):1272-5. PubMed ID: 3685977
[TBL] [Abstract][Full Text] [Related]
16. Point mutations of the BCL-6 gene in Burkitt's lymphoma.
Capello D; Carbone A; Pastore C; Gloghini A; Saglio G; Gaidano G
Br J Haematol; 1997 Oct; 99(1):168-70. PubMed ID: 9359519
[TBL] [Abstract][Full Text] [Related]
17. Normal expression of a rearranged and mutated c-myc oncogene after transfection into fibroblasts.
Richman A; Hayday A
Science; 1989 Oct; 246(4929):494-7. PubMed ID: 2683072
[TBL] [Abstract][Full Text] [Related]
18. Construction of Escherichia coli vectors for expression and mutagenesis: synthesis of human c-Myc protein that is initiated at a non-AUG codon in exon 1.
Date T; Tanihara K; Numura N
Gene; 1990 May; 90(1):141-4. PubMed ID: 2199326
[TBL] [Abstract][Full Text] [Related]
19. The intron enhancer of the immunoglobulin kappa gene activates c-myc but does not induce the Burkitt-specific promoter shift.
Polack A; Strobl L; Feederle R; Schweizer M; Koch E; Eick D; Wiegand H; Bornkamm GW
Oncogene; 1991 Nov; 6(11):2033-40. PubMed ID: 1945409
[TBL] [Abstract][Full Text] [Related]
20. Clustered somatic mutations in and around first exon of non-rearranged c-myc in Burkitt lymphoma with t(8;22) translocation.
Szajnert MF; Saule S; Bornkamm GW; Wajcman H; Lenoir GM; Kaplan JC
Nucleic Acids Res; 1987 Jun; 15(11):4553-65. PubMed ID: 3035497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
